Carpegen GmbH

Carpegen is a provider of high quality molecular diagnostics. The company focuses on developing and out-licensing real-time PCR assays/kits and point-of-care diagnostics for the diagnosis of specific infections and the detection of genetic biomarkers. As a quality market leader in dental diagnostics Carpegen provides the diagnostic testing system Carpegen Perio Diagnostics for the detection and quantification of periodontal pathogens in gingival samples. This high-quality test is used since 2003 by European dentists for optimizing periodontal therapy. In point-of-care diagnostics, Carpegen has developed the proprietary Gyronimo platform, a benchmarking point-of-care PCR system, delivering rapid, easy-to-use, highly specific & sensitive and highly cost- & personnel-efficient pathogen and genetic marker diagnostics in a broad range of infectious diseases and industrial applications. In December 2016, Carpegen sold the Gyronimo platform to clinical diagnostic specialist Curetis GmbH. Th...